Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy
For a study, researchers sought to report the clinical presentation and natural history of...
Read MoreJun 9, 2022
For a study, researchers sought to report the clinical presentation and natural history of...
Read MoreApr 11, 2022
MONDAY, April 11, 2022 (HealthDay News) — For patients with obstructive hypertrophic...
Read MoreJan 14, 2022
There is only limited experience using wearable cardioverter-defibrillators (WCD) in juvenile...
Read MoreDec 15, 2021
Two recent randomized trials show success with metoprolol and mavacamten Results from two...
Read MoreOct 18, 2021
Hypertrophic cardiomyopathy (HCM) is a genetically acquired disease of cardiac myocytes. Studies...
Read MoreSep 8, 2021
An American trial investigated the potential of valsartan in slowing the course of disease in hypertrophic cardiomyopathy (HCM). The results showed a significantly positive influence on relative cardiac remodeling in the...
Read MoreApr 5, 2021
The aim of this study was to systematically review and quantitatively synthesize existing evidence about the prognostic value of LV apical aneurysm in patients with HCM.Hypertrophic cardiomyopathy (HCM) represents a common...
Read MoreMar 25, 2021
Management of young adults with hypertrophic cardiomyopathy (HCM) is challenging.To evaluate the...
Read MoreJan 11, 2021
Metabolic abnormalities have been associated with long-term cardiac mortality in patients with...
Read MoreDec 22, 2020
MONDAY, Dec. 21, 2020 (HealthDay News) — Updated clinical practice guidelines from the...
Read MoreNov 23, 2020
This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides...
Read MoreNov 17, 2020
Results from the multicentre, phase 3 EXPLORERHCM trial highlight the benefits of a...
Read MoreNov 5, 2020
Hypertrophic cardiomyopathy (HCM) is significantly associated with high risk of fatal ventricular arrhythmias (VAs). Increased frontal QRST angle (fQRSTa), Tpe interval, and Tp-e/QTc ratio are described as ventricular...
Read MoreOct 15, 2020
The incremental prognostic value of left atrial (LA) dysfunction, emerging in various clinical...
Read MoreSep 15, 2020
Obstructive hypertrophic cardiomyopathy (HCM) is a condition in which the heart muscles become...
Read MoreSep 9, 2020
Nonobstructive hypertrophic cardiomyopathy (HCM) is a condition in which a portion of the heart...
Read MoreSep 3, 2020
Hypertrophic cardiomyopathy (HCM) is the commonest genetic cardiac disease, with a prevalence of...
Read MoreAug 24, 2020
N-terminal pro B-type natriuretic peptide (NT-proBNP) and cardiac troponin-I (cTnI) are biomarkers...
Read MoreAug 20, 2020
Obesity is one of the leading causes of non-specific mortality across the world. One of the...
Read MoreAug 20, 2020
Identifying hypertrophic cardiomyopathy (HCM) patients who warrant a primary-prevention...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.